PaxMedica (PXMD) Competitors $0.12 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends PXMD vs. HOTH, GTBP, NCNA, BFRI, LIXT, GHSI, ONCT, PCSA, XCUR, and FRTXShould you be buying PaxMedica stock or one of its competitors? The main competitors of PaxMedica include Hoth Therapeutics (HOTH), GT Biopharma (GTBP), NuCana (NCNA), Biofrontera (BFRI), Lixte Biotechnology (LIXT), Guardion Health Sciences (GHSI), Oncternal Therapeutics (ONCT), Processa Pharmaceuticals (PCSA), Exicure (XCUR), and Fresh Tracks Therapeutics (FRTX). These companies are all part of the "pharmaceutical products" industry. PaxMedica vs. Hoth Therapeutics GT Biopharma NuCana Biofrontera Lixte Biotechnology Guardion Health Sciences Oncternal Therapeutics Processa Pharmaceuticals Exicure Fresh Tracks Therapeutics Hoth Therapeutics (NASDAQ:HOTH) and PaxMedica (NASDAQ:PXMD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Do institutionals & insiders hold more shares of HOTH or PXMD? 7.1% of Hoth Therapeutics shares are owned by institutional investors. Comparatively, 4.9% of PaxMedica shares are owned by institutional investors. 10.6% of Hoth Therapeutics shares are owned by company insiders. Comparatively, 1.0% of PaxMedica shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has stronger valuation & earnings, HOTH or PXMD? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHoth TherapeuticsN/AN/A-$7.84M-$1.61-0.55PaxMedicaN/AN/A-$18.29MN/AN/A Which has more risk and volatility, HOTH or PXMD? Hoth Therapeutics has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Comparatively, PaxMedica has a beta of -0.62, meaning that its stock price is 162% less volatile than the S&P 500. Does the MarketBeat Community favor HOTH or PXMD? Hoth Therapeutics received 70 more outperform votes than PaxMedica when rated by MarketBeat users. However, 100.00% of users gave PaxMedica an outperform vote while only 65.14% of users gave Hoth Therapeutics an outperform vote. CompanyUnderperformOutperformHoth TherapeuticsOutperform Votes7165.14% Underperform Votes3834.86% PaxMedicaOutperform Votes1100.00% Underperform VotesNo Votes Is HOTH or PXMD more profitable? Hoth Therapeutics' return on equity of -81.78% beat PaxMedica's return on equity.Company Net Margins Return on Equity Return on Assets Hoth TherapeuticsN/A -81.78% -74.38% PaxMedica N/A -3,167.89%-560.35% Do analysts recommend HOTH or PXMD? Hoth Therapeutics presently has a consensus target price of $3.50, indicating a potential upside of 293.26%. PaxMedica has a consensus target price of $3.00, indicating a potential upside of 2,442.37%. Given PaxMedica's higher probable upside, analysts plainly believe PaxMedica is more favorable than Hoth Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hoth Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33PaxMedica 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor HOTH or PXMD? In the previous week, Hoth Therapeutics had 4 more articles in the media than PaxMedica. MarketBeat recorded 4 mentions for Hoth Therapeutics and 0 mentions for PaxMedica. PaxMedica's average media sentiment score of 0.00 beat Hoth Therapeutics' score of -0.16 indicating that PaxMedica is being referred to more favorably in the news media. Company Overall Sentiment Hoth Therapeutics Neutral PaxMedica Neutral SummaryHoth Therapeutics beats PaxMedica on 11 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXMD vs. The Competition Export to ExcelMetricPaxMedicaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.34M$6.75B$5.04B$8.43BDividend YieldN/A7.94%7.52%4.16%P/E RatioN/A12.17130.2316.67Price / SalesN/A270.431,720.2276.26Price / CashN/A46.0936.9133.54Price / Book0.265.284.604.98Net Income-$18.29M$151.33M$114.94M$224.26M7 Day PerformanceN/A0.30%0.14%1.65%1 Month Performance-2.16%14.88%10.15%6.92%1 Year Performance-95.46%36.87%33.87%26.46% PaxMedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXMDPaxMedica1.3208 of 5 stars$0.12flat$3.00+2,442.4%-95.5%$1.34MN/A0.002HOTHHoth Therapeutics3.2869 of 5 stars$0.88-0.6%$3.50+300.0%-31.2%$4.69MN/A-0.544Upcoming EarningsAnalyst ForecastGap UpGTBPGT Biopharma0.3058 of 5 stars$3.27-0.9%N/A-64.8%$4.63MN/A0.008Upcoming EarningsNCNANuCana3.0546 of 5 stars$1.75-0.6%$25.00+1,328.6%-86.9%$4.63MN/A-0.1430Positive NewsBFRIBiofrontera2.3851 of 5 stars$0.88-0.6%$7.00+691.4%-75.5%$4.50M$35.24M-0.1570Gap DownLIXTLixte Biotechnology0.586 of 5 stars$2.00+52.3%N/A-32.7%$4.49MN/A-1.123Positive NewsGap UpHigh Trading VolumeGHSIGuardion Health Sciences1.6271 of 5 stars$3.29flatN/A-47.6%$4.44M$12.23M0.6810Upcoming EarningsGap DownONCTOncternal Therapeutics2.4467 of 5 stars$1.48+3.1%$20.00+1,252.2%-79.2%$4.38M$790,000.00-0.1230Analyst ForecastPCSAProcessa Pharmaceuticals2.399 of 5 stars$1.33-1.5%$6.00+351.1%-83.5%$4.34MN/A-0.3420Negative NewsXCURExicure2.3529 of 5 stars$2.50+3.7%N/A+401.6%$4.33M$28.83M-0.5550FRTXFresh Tracks TherapeuticsN/A$0.72+1.4%N/A-18.9%$4.30M$8.01M-0.5120 Related Companies and Tools Related Companies HOTH Alternatives GTBP Alternatives NCNA Alternatives BFRI Alternatives LIXT Alternatives GHSI Alternatives ONCT Alternatives PCSA Alternatives XCUR Alternatives FRTX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PXMD) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PaxMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PaxMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PXMD Stock Alerts